In contrast, patients with PHP1B typically exhibit isolated or predominant PTH resistance with an absence of AHO presentations and are caused by epigenetic alterations (aberrant methylation) at the GNAS locus (Urakawa et al., 2023), leading to delayed diagnosis and treatment. Here, PTH is linked to pseudohypoparathyroidism type 1A.